Health Catalyst (HCAT) Misses Q1 EPS by 56c

Health Catalyst (NASDAQ: HCAT) reported Q1 EPS of ($0.60), $0.56 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $73.87 million versus the consensus estimate of $71.23 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c